Metabolic research
01Quality sourced02Secure shipping
Approved drug exists 2 in stock
Metabolic research
Tirzepatide
Strength · 60 MGDual GIP/GLP-1 signaling with robust clinical evidence supporting weight and glucose management in approved medicines.
Price$240USD
Add this item now, then send the complete order from your cart.
Research overview
Tirzepatide
in context.
Tirzepatide activates both GIP and GLP-1 receptors. It is extensively studied for integrated metabolic signaling involving glucose-dependent insulin response, appetite regulation, and body-weight change.
Research highlights
- 01Dual incretin-receptor pathway
- 02Strong human clinical evidence
- 03Metabolic and appetite signaling
Product details
- Presentation
- 60 MG
- Availability
- Available now · 2
- Ordering
- Cart checkout with a ready-to-send order message
- Intended use
- Laboratory, analytical, or educational research
For research use only. Not for human or veterinary consumption. No dosage, administration, medical advice, or research protocols are provided.
Explore the catalog